324377 Donepezil Hydrochloride - Calbiochem

324377
  
Az ár letöltése folyamatban...
Az ár nem tölthető be
Minimum Quantity needs to be mulitiple of
Megrendelés befejezésekor További információ
Elmentette a ()-t
 
Árajánlat kérése
Korlátozott elérhetőségKorlátozott elérhetőség
Készleten 
Megszűnt
Korlátozott mennyiségben elérhető
Az elérhetőség megerősítésre vár
    Remaining : Will advise
      Remaining : Will advise
      Tanácsadás
      Lépjen kapcsolatba a vevőszolgálattal
      Contact Customer Service

       

      Lépjen kapcsolatba a vevőszolgálattal

      Áttekintés

      Replacement Information

      Kulcsspecifikációk táblázata

      Empirical Formula
      C₂₄H₂₉NO₃HCl
      Description
      Overview

      This product has been discontinued.



      A brain-penetrating, reversible, and selective piperidine acetylcholinesterase inhibitor with an IC50 = 5.7 nM in vitro, and a 1250-fold selectivity over butylcholinesterase. In vivo, there is a marked and significant increase in acetylcholine content in rat cerebral cortex at a p.o. dose of 5 mg/kg. Furthermore, it inhibits brain cholinesterase (ChE) dose-dependently (ID50 = 2.6 mg/kg) without any marked adverse effects on ChE in the heart and small intestine. In a clinical trial, it has been shown to reduce AChE activity by 63.7% for the 5mg/d group and 77.3% for the 10mg/d group in Alzheimer's disease patients. Its off-target effects are indicated with the reversibly of inhibited voltage-gated K+/Na+ channels.

      Catalogue Number324377
      Brand Family Calbiochem®
      SynonymsE2020, (R,S)-1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]-methylpiperidine hydrochloride
      References
      ReferencesYu, B., et al. 2005. Eur J Pharm 508, 15.
      Ogura, H., et al. 2000. Nippon Yakurigaky Zasshi 115, 45.
      Sugimoto, H., et al. 1995. J Med Chem 38, 4821.
      Rogers, S., et al. 1998. Neurology 50, 136.
      Product Information
      FormWhite solid
      Hill FormulaC₂₄H₂₉NO₃HCl
      Chemical formulaC₂₄H₂₉NO₃HCl
      Structure formula ImageStructure formula Image
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Donepezil Hydrochloride - Calbiochem MSDS

      Title

      Safety Data Sheet (SDS) 

      Donepezil Hydrochloride - Calbiochem Certificates of Analysis

      TitleLot Number
      324377

      References

      Hivatkozások áttekintése
      Yu, B., et al. 2005. Eur J Pharm 508, 15.
      Ogura, H., et al. 2000. Nippon Yakurigaky Zasshi 115, 45.
      Sugimoto, H., et al. 1995. J Med Chem 38, 4821.
      Rogers, S., et al. 1998. Neurology 50, 136.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision09-November-2011 RFH
      SynonymsE2020, (R,S)-1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]-methylpiperidine hydrochloride
      DescriptionA brain-penetrating, reversible, and selective piperidine acetylcholinesterase inhibitor with an IC50 = 5.7 nM in vitro, and a 1250-fold selectivity over butylcholinesterase. In vivo, there is a marked and significant increase in acetylcholine content in rat cerebral cortex at a p.o. dose of 5 mg/kg. Furthermore, it inhibits brain cholinesterase (ChE) dose-dependently (ID50 = 2.6 mg/kg) without any marked adverse effects on ChE in the heart and small intestine. In a clinical trial, it has been shown to reduce AChE activity by 63.7% for the 5mg/d group and 77.3% for the 10mg/d group in Alzheimer's disease patients. Its off-target effects are indicated with the reversibly of inhibited voltage-gated K+/Na+ channels.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₂₄H₂₉NO₃HCl
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (16 mg/ml)
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesYu, B., et al. 2005. Eur J Pharm 508, 15.
      Ogura, H., et al. 2000. Nippon Yakurigaky Zasshi 115, 45.
      Sugimoto, H., et al. 1995. J Med Chem 38, 4821.
      Rogers, S., et al. 1998. Neurology 50, 136.